Henry Schein Inc. (NASDAQ:HSIC) has earned a consensus rating of “Hold” from the eleven analysts that are covering the firm. Eight equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $174.02.
HSIC has been the topic of a number of analyst reports. Bank of America Corp. initiated coverage on shares of Henry Schein in a research note on Monday, September 12th. They set a “buy” rating and a $185.00 target price on the stock. Goldman Sachs Group Inc. raised shares of Henry Schein from a “neutral” rating to a “buy” rating and set a $185.00 target price on the stock in a research note on Tuesday, October 11th. Zacks Investment Research raised shares of Henry Schein from a “sell” rating to a “hold” rating in a research note on Wednesday, October 5th. JPMorgan Chase & Co. reaffirmed a “hold” rating and set a $163.00 target price on shares of Henry Schein in a research note on Thursday, November 3rd. Finally, Leerink Swann reaffirmed a “hold” rating on shares of Henry Schein in a research note on Thursday, November 3rd.
In other Henry Schein news, Director Kurt P. Kuehn acquired 1,000 shares of the company’s stock in a transaction that occurred on Monday, December 12th. The stock was purchased at an average price of $151.41 per share, for a total transaction of $151,410.00. Following the completion of the acquisition, the director now owns 2,039 shares of the company’s stock, valued at approximately $308,724.99. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Mark E. Mlotek sold 2,417 shares of Henry Schein stock in a transaction that occurred on Thursday, November 3rd. The shares were sold at an average price of $155.19, for a total transaction of $375,094.23. Following the completion of the transaction, the executive vice president now owns 40,456 shares of the company’s stock, valued at approximately $6,278,366.64. The disclosure for this sale can be found here. 1.27% of the stock is currently owned by corporate insiders.
Shares of Henry Schein (NASDAQ:HSIC) traded down 0.43% during midday trading on Wednesday, hitting $152.83. 178,170 shares of the stock traded hands. The company has a market cap of $12.30 billion, a price-to-earnings ratio of 25.38 and a beta of 1.05. The stock has a 50-day moving average of $152.76 and a 200-day moving average of $164.68. Henry Schein has a 52-week low of $142.64 and a 52-week high of $183.00.
Henry Schein (NASDAQ:HSIC) last issued its earnings results on Wednesday, November 2nd. The company reported $1.68 EPS for the quarter, topping analysts’ consensus estimates of $1.65 by $0.03. Henry Schein had a net margin of 4.40% and a return on equity of 18.15%. The company had revenue of $2.87 billion for the quarter, compared to the consensus estimate of $2.88 billion. During the same period in the previous year, the firm earned $1.55 earnings per share. Henry Schein’s quarterly revenue was up 6.7% compared to the same quarter last year. On average, equities analysts predict that Henry Schein will post $6.58 earnings per share for the current fiscal year.
Henry Schein Company Profile
Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.
